Action of mouthwashes on Staphylococcus spp: isolated in the saliva of community and hospitalized individuals by ANDRADE, Denise de et al.
*Correspondence: D. Andrade. Faculdade de enfermagem, Universidade de 
São Paulo –Ribeirão Preto, Av. Bandeirantes 3.900, Monte Alegre, 14.040.902 
- Ribeirão Preto-SP, Brazil. E-mail: dandrade@eerp.usp.br
A
rt
ic
leBrazilian Journal of 
Pharmaceutical Sciences
vol. 45, n. 3, jul./sep., 2009
Action of mouthwashes on Staphylococcus spp. isolated in the 
saliva of community and hospitalized individuals
Denise de Andrade1, Paula Regina de Souza1, Carolina Contador Beraldo1, 
Evandro Watanabe2, Mery Elen Lima1, Vanderlei José Haas1
1College of Nursing at Ribeirão Preto, University of São Paulo, 
2Faculty of Pharmaceutical Sciences at Ribeirão Preto, University of São Paulo
The use of mouthwashes in critical patients has been a source of concern for health professionals due to 
the diverse range of products, causing uncertainty about which is the most indicated. This study aimed to 
assess the susceptibility of Staphylococcus spp. isolated in the saliva of individuals from the community 
and patients in Intensive Care Units (ICU) as to antiseptic mouthwashes. The following oral antiseptics 
were assessed: cetylpyridinium chloride solution, Listerine® and Neen®. Calcium alginate swab was 
used for saliva collection to isolate Staphylococcus spp. Microbiological processing involved growth, 
isolation, strain identification and determination of MID (maximum inhibitory dilution). MID was 
considered the greatest dilution that completely inhibited the strains. The products efficacy was analyzed 
by a two-factor ANOVA repeated measures and by Bonferroni adjustments in multiple comparisons, 
considering a significance level of α=0.05. In total, 80 strains of Staphylococcus spp. were isolated, 
40 from ICU patients and 40 from community individuals. MID results revealed that cetylpyridinium 
chloride solution presented better results in comparison to other products, that is, 39 (97.5%) strains 
from hospital patients with MID 1:128, and 37 (92.5%) of individuals from the community had MID 
1:64. Neen® inhibited all strains in both groups at a dilution from 1:2 to 1:4. Listerine® presented the 
worst MID results, 65% of the strains from individuals from the community and 10% of hospital strains 
were not inhibited at a dilution of 1:2.
Uniterms: Oral health. Staphylococcus spp. Mouthwashes. Oral hygiene.
O uso de antissépticos bucais tem sido uma das preocupações dos profissionais de saúde considerando a 
diversidade de produtos, o que traz a insegurança sobre qual é o mais adequado. Objetivou-se avaliar a 
suscetibilidade de Staphylococcus spp. isolado da saliva de indivíduos adultos da comunidade e do hospital 
frente a antissépticos bucais. Os antissépticos avaliados foram: solução de Cloreto de Cetilpiridínio, 
Listerine® e Neen®. Na coleta de saliva para o isolamento do Staphylococcus spp. utilizou-se o swab de 
alginato de cálcio. O processamento microbiológico envolveu o crescimento, isolamento, identificação 
das cepas, determinação da DIM. Foi considerada DIM a maior diluição que inibiu completamente as 
cepas. A eficácia dos produtos foi avaliada por meio da análise de variância (ANOVA) bilateral com 
medidas repetidas, e pelo método de ajuste de Bonferroni nas comparações múltiplas, com um nível de 
significância α=0,05. Totalizou-se 80 cepas de Staphylococcus spp. sendo 40 isoladas de pacientes da 
UTI e 40 de indivíduos da comunidade. Comparando os resultados é possível verificar que a solução 
de cloreto de cetilpiridínio apresentou melhores resultados em relação aos demais produtos, ou seja, 39 
(97,5%) das cepas hospitalares DIM 1:128 e da comunidade 37 (92,5%) DIM 1:64. Para Neen® nos dois 
grupos a DIM foi de 1:2 e 1:4. Listerine® apresentou o pior resultado em termos da DIM, sendo que 65% 
das cepas da comunidade e 10% hospitalar não foram inibidas na diluição 1:2. 
Unitermos: Saúde bucal. Staphylococcus spp. Antissépticos bucais. Higiene bucal.
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MATERIALS AND METHODS
Experimental (laboratory) study with Staphylococ-
cus spp. strains isolated from the saliva of individuals from 
the community and patients hospitalized in the Intensive 
Care Unit (ICU) with orotracheal tubes and subject to 
mechanical ventilation. The following antiseptic mou-
thwashes were assessed: 
Cetylpyridinium Chloride (CPC) – solution pre-
pared in the pharmacy of the hospital under study. Each 
milliliter of the solution contains 0.25% Cetylpyridinium 
Chloride, 0.2625 saccharin, 0.525 mL of water soluble mint 
extract, sicovit yellow CI 15-985 and distilled water q.s.p.
Listerine®,  produced by “Pfizer Consumer 
Healthcare’s”, its chemical composition contains essential 
oils, thymol, menthol or eucalyptol and methyl salicylate; 
water and alcohol 26.9% and pH 5.0. Producer recommen-
ds rinsing for 30 seconds with 20 mL of Listerine® after 
each brushing and dental floss use. It should not be diluted 
and is not recommended for children under 12 years old.
Neen®, natural product produced by Floresça Indús-
tria e Comércio de Cosméticos Ltda/SATTIVA-Goiânia-
GO. It is composed of 2% propolis tincture, 2% licorice 
extract, 0.1% eucalyptus oil, 0.1% mint oil and 1% neem 
(Azadirachta indica) tincture.
Determination of the Maximum Inhibitory Dilution 
(MID) of the antiseptic mouthwashes as to Staphylococcus 
spp., in the community and in hospital patients, was car-
ried out in 96-well microtitration plates (microtit plates). 
Mouthwashes were subject to serial double dilution of 1:2, 
1:4, 1:8, 1:16 until 1:1024 in 20 ml test tubes.
These dilutions were poured into Petri plates 
(20x100mm) with Mueller Hinton Broth (Difco®) media 
and antiseptic, double concentration (2n). Afterwards, 
using a mutichannel pipette (8 channels), 100,0 µL were 
distributed in each well of the microtit plates, starting from 
column 10 (1:1024) to column 1 (1:2). Using the muti-
channel pipette, 5.0µl of standardized microbial suspen-
sion (0.5 McFarland scale) were injected in each well of 
the microtit plates, containing antiseptic diluted in culture 
media. Microtit plates were stored in a Tupperware plastic 
container and incubated at 35 ºC for 24 hours (Figure 1). 
Reading was done with a stereomicroscope (Nikon, 
JP) under reflected light after inoculation of 2.0 µL of 
triphenyltetrazolium chloride solution (TTC-Merck®) at 
200 mg concentration in each well of the plate and incu-
bation at 35 ºC for approximately 30 minutes, to indicate 
the viability of the microorganisms (reddish color).
Dilution that caused complete inhibition of the mi-
crobial development was considered the Maximum Inhi-
bitory Dilution. Figure 1 describes the MID phases. The 
INTRODUCTION
Research developed in the last decades has shown 
the clinical condition of the mouth as an important attri-
bute in the context of individuals’ comprehensive health. 
Literature associates oral health as a risk factor for many 
clinical, specially infectious, complications (Diaz et al., 
2000; Machado et al., 2000; Nelson et al., 2005). Thus, 
oral health care does not target only beautiful and healthy 
teeth, it participates significantly in quality of life.
It is presumed that mouth contains approximately 
550 to 600 species of bacteria, besides viruses and fungus. 
Among the bacteria, there are the Actinomyces israeli, 
Capnocytophaga spp., Eikenella corrodens, Staphylo-
coccus spp., Streptococcus mitis (Machado et al., 2000; 
Nelson et al., 2005). It is worth highlighting that oral 
microbiota coexists harmonically with the host, that is, 
keeps a microbiological homeostasis, commensalism, but 
for many factors can become pathogenic.
Although Staphylococcus spp., particularly, is part 
of individuals’ normal microbiota, in determinate condi-
tions it can cause infections, very frequent in hospitals 
(Diaz et al., 2000; Cavalcanti et al., 2005; Andrade, Leo-
poldo, Haas, 2006).
Researchers highlight that patients hospitalized in 
Intensive Care Units (ICU) are more vulnerable to develop 
infections deriving from oral microbiota or dental plaque 
biofilm (Bauer et al., 2002; Babcok et al., 2004; Brennan 
et al., 2004; Gusmão, Dourado, Fiaccone, 2004; Caval-
canti et al., 2005; Safdar, Crnich, Maki, 2005; Andrade, 
Leopoldo, Haas, 2006).
In addition, it is opportune to highlight the concept 
of dental plaque biofilm as the disposal of microorganisms 
in many layers, forming microbial communities highly 
resistant to phagocytes and antibiotics (Costerton, Stewart, 
Greenberg, 1999). If the bacterial plaque or the biofilm 
are not regularly removed by hygienization, they can 
cause caries and periodontal problems, such as gingivitis, 
among others. 
Considerations concerning the oropharynx micro-
biota of critical patients in the ICU and the formation of 
the biofilm in the endotracheal tube have triggered ques-
tions worth researching. Currently, the use of antiseptic 
mouthwashes deserves attention, as their action reduce 
the microbial charge.
Besides using chemical products to fight microorga-
nisms, it is necessary to know their efficacy against them, 
sometimes in hospitals, others in the community. Thus, this 
study aimed to assess susceptibility of Staphylococcus spp., 
isolated in the saliva of adult individuals from the commu-
nity and hospitalized patients, to antiseptic mouthwashes.
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study was approved by the Research Ethics Committee. 
For statistical analysis of the results, MID original 
values were subject to a logarithmic transformation, 
aiming to reduce the variability of this indicator. Thus, 
two-factors analysis of variance (ANOVA) with repeated 
measures was used: 
●intra-subjects: antiseptic mouthwashes - cetyl-
pyridinium chloride (CPC), Listerine® (L) and Neen® (N)
●inter-subjects: origin of strains, from Hospital (H) 
and from the Community (C). 
The Statistical Package for the Social Sciences 
(SPSS), version 15.0, was used for all analyses, conside-
ring level of significance α=0.05. For analysis of multiple 
comparisons, Bonferroni’s adjustment method was used.
RESULTS
In total, 80 strains were analyzed, 40 isolated in the 
saliva of patients hospitalized in the ICU and 40 in indi-
viduals from the community. 
Regarding the species, 75.8% of S. aureus was 
identified in the saliva of hospitalized patients and 24.4% 
in individuals from the community. 
Tables I, II and III show the distribution of the 
Maximum Inhibitory Dilution of the analyzed antiseptic 
mouthwashes (CPC, Listerine®, and Neen®). 
Table IV presents the mean and standard deviation 
for MID values in logarithmic scale (natural logarithm), 
clearly indicating the superiority of the cetylpyridinium 
chloride solution, always with higher MIDs for hospital 
strains in the analyzed products. In fact, a two-factor repe-
ated ANOVA measure (Table V) permits to identify that, 
for an 0.05 level of significance, the origin of the strains 
is statistically significant for each of the products (inter-
subject factor), except for listerine.
The cetylpyridinium chloride solution was the only 
one to show inhibitory dilution in the interval from 1:32 to 
1:4096, and the highest number of strains inhibited ranged 
from 1:128 to 1:1024. Besides that, for each treatment, 
MID values are higher for hospital strains, being also 
considered statistically significant the difference for all 
three treatments. The statistical analyses show that there 
is no doubt about CPC efficacy in the two groups of strains 
(hospital and community). 
Regarding the other products assessed (Listerine® 
and Neen®), inhibitory dilutions varied from 1:2 to 1:64 
in the two groups (hospital and community). The antisep-
tic mouthwash Listerine® presented the worst result as to 
MID, as it did not have inhibitory action at any dilution 
in 26 community strains and the same result was shown 
in 4 hospital strains.
DISCUSSION AND CONCLUSION
According to Tables I and III, the cetylpyridinium 
chloride solution presented better Maximum Inhibitory 
Dilution (MID) results. It is highlighted that the solution is 
produced in the pharmacy of the hospital under study and 
FIGURE 1 - Flow chart of antiseptic mouthwashes MID.
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TABLE I - Numbers, Percentages and Accumulated frequency F(a) of the MID of CPC mouthwash as to Staphylococcus spp. isolated 
in the saliva of individuals from the community and hospital. Ribeirão Preto. 2006
MID (CPC) Staphylococcus spp.
Community Hospital
F(a) F(a)
N % N % N % N %
1/4096 1 2.5 1 2.5
1/2048 5 12.5 6 15.0
1/1024 1 2.5 1 2.5 4 10.0 10 25.0
1/512 4 10.0 5 12.5 12 30.0 22 55.0
1/256 22 55.0 27 67.5 15 37.5 37 92.5
1/128 4 10.0 31 77.5 2 5.0 39 97.5
1/64 6 15.0 37 92.5 1 2.5 40 100.0
1/32 3 7.5 40 100.0
Total 40 100.0 40 100.0
TABLE II - Numbers, Percentages and Accumulated frequency F(a) of the MID of Listerine® as to Staphylococcus spp. isolated in 
the saliva of individuals from the community and hospital. Ribeirão Preto. 2006
MID 
Listerine®
Staphylococcus spp.
Community Hospital
F(a) F(a)
N % N % N % N %
1/512 1 2.5 1 2.5
1/16 1 2.5 2 5.0 1 2.5 1 2.5
1/8 1 2.5 3 7.5 1 2.5 2 5.0
¼ 5 12.5 8 20.0 4 10.0 6 15.0
½ 6 15.0 14 35.0 30 75.0 36 90.0
No action 26 65.0 4 10.0
Total 40 100.0 40 100.0
According to data from table 2, Listerine® inhibited only 14 (35%) of Staphylococcus spp. community strains at a dilution 1:2, 
against 36 (90%) hospital strains at the same dilution. 
TABLE III - Numbers, Percentages and Accumulated frequency F(a) of the MID of Neen® (N) as to Staphylococcus spp. isolated in 
the saliva of individuals from the community and hospital. Ribeirão Preto. 2006
MID Neen® Staphylococcus spp.
Community Hospital
F(a) F(a)
N % N % N % N %
1/64 1 2,5 1 2.5
1/32 1 2.5 1 2.5
1/16 3 7.5 4 10.0 3 7.5 4 10.0
1/8 9 22.5 13 32.5 24 60.0 28 70.0
¼ 26 65.0 39 97.5 12 30.0
½ 1 2.5
Total 40 100.0 40 100.0
The antiseptic mouthwashe Neen®, at dilution 1:4, inhibited 39 (97.5%) of community strains and, at dilution 1:8, inhibited 28 
(70%) hospital strains. 
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TABLE IV - Position measures and logarithm variability of the 
MID of the three antiseptic mouthwahses regarding community 
and hospital strains
MID –
X
ρ
CPC
Listerine
Neen
Hospitalized
Community
Total
Hospitalized
Community
Total
Hospitalized
Community
Total
6.1517
5.2159
5.6838
0.7798
0.5545
0.6672
1.9755
1.6809
1.8282
0.89054
0.81544
0.97028
0.50100
1.14489
0.88535
0.53346
0.54119
0.55412
Legend: -x-mean ρ- standard deviation
Table V - Analysis of variance with repeated measures of MID for the three antiseptic mouthwashes (CPC, L and N) in two groups 
of strains, community and hospital (C,H)
Mouthwashes/ strains Differences among means (р) 95% confidence interval 
CPC/ (H and C) 0.936 < 0.001 0.556 1.316
L/ (H and C) 0.225 0.258 -0.168 0.619
N/ (H and C) 0.295* 0.016 0.055 0.534
CPC/L 5.017 < 0.001 4.697 5.336
CPC/N 3.856 < 0.001 3.599 4.112
L/N -1.161* < 0.001 -1.375 -0.947
has been used in patients, including the ones hospitalized 
in the ICU.
In Brazil, there is lack of literature on the theme, as 
few studies assessed the antimicrobial action of antiseptic 
mouthwashes. Thus, it is important to mention Monfrin 
and Ribeiro’s (2000) study, who evaluated the efficacy of 
antiseptic mouthwashes (Kolynos, produced by Kolynos 
do Brasil; Bucal-B, produced by Gillette do Brasil; Ce-
pacol, produced by Hoechst Marion Roussel; Periogard, 
produced by Colgate-Palmolive; Flogbucal, produced 
by Asta Médica; Malvatricin, produced by Laboratório 
Daudt Oliveira Ltda.; Fluordent, produced by Johnson 
& Johnson; Wash, produced by Abbott Laboratórios do 
Brasil Ltda.; Plax, produced by Pfizer do Brasil (currently 
Colgate-Palmolive) and Listerine from Johnson & Johnson 
in the reduction of saliva microbiota. Samples from the 
saliva of 50 individuals aged between 19 and 54 years were 
selected. After cultivation of the sample microorganisms, 
the ten different antiseptic mouthwashes were inoculated 
in three dosages (10 µl, 20 µl, 25 µl). Results revealed 
that Periogard was more effective in the reduction of the 
saliva microbiota, and that Listerine and Flogbucal were 
ineffective in relation to antimicrobial activity.
Other researchers, such as Witt et al. (2005) and 
Tirapelli and Ito (2003), showed that the use of cetylpyri-
dinium chloride reduces the number of microorganisms in 
the mouth, specially Streptococcus. In addition, it has also 
been evidenced that chlorhexidine gluconate use in mou-
thwashes significantly reduces the population of aerobic 
and anaerobic bacteria in the mouth (Charles et al., 2005). 
Carvalho (1989) correlated the index of plaque with 
brushing, with sodium fluoride and cetylpyridinium chlori-
de mouth rinse. It was concluded that brushing associated 
with cetylpyridinium chloride mouth rinse is a promising 
hygiene behavior regarding the control of the index of 
dental plaque biofilm. 
Pinheiro (1991) assessed, in vitro, the effect of ce-
tylpyridinium chloride and sodium fluoride in the fermen-
tation and synthesis of insoluble extracellular polysaccha-
rides of dental plaque. The 1:10 dilution of this substance 
inhibited 96% of the fermentation acids and 100% of the 
synthesis of insoluble polysaccharides. Considering that 
the dilution normally used in mouth rinse is 1:2, it was 
concluded that this is a highly effective collutory against 
dental plaque microorganisms. 
Garib et al. (1995) evaluated the efficacy of mouth rin-
se with 0.12% chlorhexidine solution and cetylpyridinium 
chloride in the reduction of dental plaque and gingivitis. The 
obtained results allowed for the following conclusions: a) 
mouth washing led to a statistically significant reduction 
of dental plaque and gingival bleeding indexes in the three 
experimental groups. Nevertheless, there was no statisti-
cally significant difference among the groups; b) isolatedly, 
cetylpyridinium chloride led to a reduction of 23.6% in den-
tal plaque and 55.9% in gingival bleeding indexes. When 
associated to chlorhexidine, it led to a 52.2% reduction in 
the index of plaque and 62.9% in the index of bleeding. 
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In general, the following products are routinely used 
in oral hygiene and in the control of dental plaque biofilm: 
Chlorhexidine (0.12%); Plax; Periogard; Noplak; Cetyl-
pyridinium Chloride - cepacol; Triclosan; Malvatricin; So-
dium Bicarbonate; Zinc chloride; Listerine; among others. 
The total amount of plaque present on the teeth surface is 
directly influenced by individual oral hygiene, and shows 
high inter-individual variation. During severe or acute 
phases of gingivitis, or when patients have a deficient pla-
que control, an associated chemical should be temporarily 
used in the control of dental plaque. These solutions should 
have in vitro antimicrobial action, and should not present 
irreversible adverse effects (APECIH, 2000).
In dental practice, intra-mouth antisepsis should be 
done with a substance compatible to the mouth mucosa 
and, thus, only water-based solutions are indicated. Another 
important issue is the toxicity of the active principles, since 
they can be ingested when used and absorbed by mouth mu-
cosa (Seabra et al., 2005). Aspects like toxicity, tolerance, 
antimicrobial action and cost justify the development of 
research to search for alternative options, such as the present 
study. Thus, the solution Neen® was evaluated, a natural 
product with almost nonexistent toxicity and low cost, if 
compared to the other products, including chlorhexidine. 
The product Listerine®, with essential oils, contains 
thymol, menthol, eucalyptol and methyl salicylate. It is 
available with 26.9% alcohol vehicle and pH 5, which 
justify adverse effects, such as burning sensation and taste. 
According to the producer’s label, it is recommended to 
be used in 30-secods rinses, twice a day. Recently, zinc 
chloride has been added to the product since, according to 
producer, it interferes in the formation of calcium phospha-
te crystals, and in the mineralization of the dental plaque, 
decreasing tartar formation.
The comparison of the results of the present study 
showed that mean and standard deviation for MID values 
in logarithmic scale indicated the superiority of the cetyl-
pyridinium chloride solution (CPC), which always had 
higher MIDs in hospital strains. Cetylpyridinium chloride, 
at 1:64 dilution, inhibited 37 (92.5%) of community strains 
and 39 (97.5%) of ICU strains. Listerine®, at 1:2 dilution, 
inhibited 14 (35%) of community strains and 36 (90%) of 
ICU strains. Neen® at 1:4 dilution inhibited 39 (97.5%) of 
community strains, and 28 (70%) of ICU strains.
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